rameters of PGCs were described in some of these reports, most of the conclusions were unreliable because of the small number of PGC cases analyzed.In the present study, we conducted a pooled analysis of 53 PGC cases, including 2 patients treated at the National Cancer Center Hospital East (NCCHE), to clarify the tumor characteristics and prognostic parameters of patients with PGC.
Case reports
Case 1A 74-year-old man complaining of loss of appetite and loss of body weight, for 9 months, visited the NCCHE. Laboratory data showed anemia (RBC, 369 ¥ 10 4 /mm 3 ; hemoglobin [Hb], 8.4 g/dl; hematocrit [Hct], 28.5%), hypoalbuminemia (serum albumin, 3.0 g/dl), and high serum carcinoembryonic antigen (CEA; 31.2 ng/ml; normal, 0-5 ng/ml).A gastrointestinal X-ray examination revealed an ulcerated lesion with a distinct elevation occupying the lower third of the stomach and invading the duodenum. The lesion was endoscopically diagnosed as a gastric cancer, and a biopsy specimen taken from its margin revealed well-differentiated tubular adenocarcinoma. A computed tomography (CT) scan and echography showed no evidence of liver metastasis at this time.A radical subtotal Billroth II gastrectomy with lymph node dissection, omentectomy, and partial resection of the pancreatic head was performed. Macroscopically, no signs of liver metastasis or retroperitoneal invasion were observed.The resected tumor was 11.5 ¥ 8.5 ¥ 5.0 cm in size. The tumor had extended to the serosa (T3) and had directly invaded the duodenum. A metastasis was found in one of the supragastric lymph nodes (N1). Grossly, the tumor was fungating (Fig. 1). Histologically, the tumor Abstract Primary gastric choriocarcinoma (PGC) is a rare tumor. In total, approximately 140 cases of PGC have been reported in the international medical literature. However, the clinical behavior, tumor characteristics, and prognostic parameters of PGC have not been clearly described. We conducted a pooled analysis to clarify the tumor characteristics and prognostic parameters in 53 patients with PGCs, including 2 patients treated at our hospital. The following variables were examined as potential prognostic factors: (1) sex, (2) age, (3) depth of invasion, (4) size, (5) histology, (6) nodal metastasis, (7) distant lymph node metastasis, (8) synchronous liver metastasis, (9) residual tumor, and (10) chemotherapy (not given or given). Univariate and multivariate analyses showed that the presence of residual tumor and synchronous liver metastasis and the absence of chemotherapy were significantly associated with an increased hazard rate (HR) of short overall survival (OS). Pooled analysis, including the two patients with PGC treated at our facility, demonstrated that the presence of a curative operation and chemotherapy, and the absence of synchronous liver metastasis were the strongest indicators of a favorable clinical course in patients with PGC.